Berhanu et al., 2014 - Google Patents
Second line failure and protease inhibitor resistance in a clinic in Johannesburg, South AfricaBerhanu et al., 2014
- Document ID
- 4816410978684863131
- Author
- Berhanu R
- Evans D
- Ive P
- Spencer D
- Firnhaber C
- Sanne I
- Fox M
- Publication year
- Publication venue
- Conference on Retroviruses and Opportunistic Infections. Boston, USA
External Links
Snippet
Background: In resource limited settings, where few options exist for patients failing second line antiretroviral therapy (ART), programmatic approaches to treatment failure must be developed. We report on an approach to standardizing care for patients on second-line in …
- 239000000137 peptide hydrolase inhibitor 0 title abstract description 6
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thanh et al. | Clinical features of three patients with paradoxical immune reconstitution inflammatory syndrome associated with Talaromyces marneffei infection | |
| Berhanu et al. | Second line failure and protease inhibitor resistance in a clinic in Johannesburg, South Africa | |
| Pinzone et al. | Prevalence of comorbidities in a cohort of women living with HIV | |
| Wong et al. | Eltrombopag in patients with chronic ITP under routine clinical practice in the middle East, Asia (East and South), and Australia: an interim analysis of the CITE study | |
| Fechtenbaum | Toxidermia: case report | |
| Ariyasinghe et al. | Catatonia following abrupt discontinuation of clozapine | |
| Newton | Opinion: Caring for those on the mental health front line | |
| Custodio et al. | Pharmacokinetics and preliminary safety of elvitegravir in HIV-1 infected pediatric subjects | |
| Ito | Liver toxicity: 2 case reports | |
| 北川功幸 et al. | Which measurement of blood pressure is more associated with albuminuria in patients with type 2 diabetes: Central blood pressure or peripheral blood pressure? | |
| DING et al. | Analysis of different levels of viral suppression in HIV-1 patients after antiviral treatment | |
| Gautier | Pancreatic tumour and multifocal hepatocellular carcinoma: 2 case reports | |
| Stott | Efavirenz/lamivudine/tenofovir disoproxil fumarate | |
| AbbVie et al. | Disclosures | |
| Snell et al. | P20 Potential impact of updated UK guidelines for use of post exposure prophylaxis following sexual exposure in a London sexual health service | |
| Marcelin et al. | NRTI-sparing regimens yield higher rates of drug resistance than NRTI-based regimens for HIV-1 treatment | |
| Mumoli | Rosacea-like facial rash: case report | |
| Takahashi | Psychotic symptoms: case report | |
| Rohr et al. | Predictors of time to switch to second line ART after first line failure in Johannesburg, South Africa | |
| Oudiz et al. | C106 MONEY DON'T MATTER TONIGHT: PULMONARY HYPERTENSION ASSESSMENT, PROGNOSTICATION, AND TREATMENT: Results Of Interim Analysis Of The Efficacy And Safety Of Bardoxolone Methyl In Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (ctd)(the Lariat Study) | |
| Fior | Weight gain, hypertrichosis and anxiety: case report | |
| Shekhovtsova | The functional state of the pancreas in patients with type 2 diabetes mellitus with different phenotype | |
| Marshall et al. | Is Kivexa with rilpivirine as effective as Eviplera for switch in clinical practice? | |
| Nishitai et al. | Successful administration of regorafenib to a metastatic colon cancer patient with impaired performance status by reducing the initial dose | |
| Ali | Deranged liver function tests in an elderly patient: case report |